Related references
Note: Only part of the references are listed.Cyclosporine Lipid Nanocapsules as Thermoresponsive Gel for Dry Eye Management: Promising Corneal Mucoadhesion, Biodistribution and Preclinical Efficacy in Rabbits
Lubna M. Eldesouky et al.
PHARMACEUTICS (2021)
Enhancing the in vitro and in vivo activity of itraconazole against breast cancer using miltefosine-modified lipid nanocapsules
Nabila A. El-Sheridy et al.
DRUG DELIVERY (2021)
Enhanced oral bioavailability of Tanshinone IIA using lipid nanocapsules: Formulation, in-vitro appraisal and pharmacokinetics
Asmaa A. Ashour et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Antihepatic Fibrosis Drugs in Clinical Trials
Yue-Cheng Guo et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2020)
Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues
Maurizio Parola et al.
MOLECULAR ASPECTS OF MEDICINE (2019)
Enhancement of macrophage uptake via phosphatidylserine-coated acetalated dextran nanoparticles
Nishan K. Shah et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2019)
The Hemocompatibility of Nanoparticles: A Review of Cell-Nanoparticle Interactions and Hemostasis
Kara M. de la Harpe et al.
CELLS (2019)
Acyclovir lipid nanocapsules gel for oromucosal delivery: A preclinical evidence of efficacy in the chicken pouch membrane model
Darine Abozaid et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Oral vitamin-A-coupled valsartan nanomedicine: High hepatic stellate cell receptors accessibility and prolonged enterohepatic residence
Nesrine S. El-Mezayen et al.
JOURNAL OF CONTROLLED RELEASE (2018)
In vitro anti-cancer activity and pharmacokinetic evaluation of curcumin-loaded lipid nanocapsules
Giovanna Lollo et al.
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2018)
Tanshinol ameliorates CCL4-induced liver fibrosis in rats through the regulation of Nrf2/HO-I and NF-kappa B/I kappa B alpha signaling pathway
Rong Wang et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
Praziquantel-lipid nanocapsules: an oral nanotherapeutic with potential Schistosoma mansoni tegumental targeting
Rokaya O. Amara et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Enhanced efficacy of curcumin with phosphatidylserine-decorated nanoparticles in the treatment of hepatic fibrosis
Ji Wang et al.
DRUG DELIVERY (2018)
Ameliorative Effect of Curcumin-Encapsulated Hyaluronic Acid-PLA Nanoparticles on Thioacetamide-Induced Murine Hepatic Fibrosis
Yu-Nong Chen et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2017)
Dermal quercetin lipid nanocapsules: Influence of the formulation on antioxidant activity and cellular protection against hydrogen peroxide
T. Hatahet et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
Hepatic stellate cell-targeted imatinib nanomedicine versus conventional imatinib: A novel strategy with potent efficacy in experimental liver fibrosis
Nesrine S. El-Mezayen et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Biocompatibility assessment of silk nanoparticles: hemocompatibility and internalization by human blood cells
Manfred F. Maitz et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2017)
Combined photothermal-chemotherapy of breast cancer by near infrared light responsive hyaluronic acid-decorated nanostructured lipid carriers
Shaohui Zheng et al.
NANOTECHNOLOGY (2017)
Combination of a chemopreventive agent and paclitaxel in CD44-targeted hybrid nanoparticles for breast cancer treatment
Bao Ngoc Tran et al.
ARCHIVES OF PHARMACAL RESEARCH (2017)
IL-6 pathway in the liver: From physiopathology to therapy
Dirk Schmidt-Arras et al.
JOURNAL OF HEPATOLOGY (2016)
Effects of tanshinone IIA on fibrosis in a rat model of cirrhosis through heme oxygenase-1, inflammation, oxidative stress and apoptosis
Ming Shu et al.
MOLECULAR MEDICINE REPORTS (2016)
Layer-by-layer-coated lyotropic liquid crystalline nanoparticles for active tumor targeting of rapamycin
May S. Freag et al.
NANOMEDICINE (2016)
Is Liver Enzyme Release Really Associated with Cell Necrosis Induced by Oxidant Stress?
Martha Lucinda Contreras-Zentella et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
Tanshinone IIA protects against acetaminophen-induced hepatotoxicity via activating the Nrf2 pathway
Wenwen Wang et al.
PHYTOMEDICINE (2016)
Use of ordered mesoporous silica-loaded phyto-phospholipid complex for BCS IV class plant drug to enhance oral bioavailability: a case report of tanshinone IIA
Ting Chen et al.
RSC ADVANCES (2016)
Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis
Hans-Theo Schon et al.
FRONTIERS IN PHARMACOLOGY (2016)
Enhanced hepatic targeting, biodistribution and antifibrotic efficacy of tanshinone IIA loaded globin nanoparticles
Zhengjie Meng et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
The carbon tetrachloride model in mice
D. Scholten et al.
LABORATORY ANIMALS (2015)
Matrix metalloproteinases in liver injury, repair and fibrosis
Sergio Duarte et al.
MATRIX BIOLOGY (2015)
In vivo evaluation of paclitaxel-loaded lipid nanocapsules after intravenous and oral administration on resistant tumor
A. C. Groo et al.
NANOMEDICINE (2015)
Miltefosine Lipid Nanocapsules for Single Dose Oral Treatment of Schistosomiasis Mansoni: A Preclinical Study
Maha M. Eissa et al.
PLOS ONE (2015)
Nanoparticle stability in biologically relevant media: influence of polymer architecture
Bethsy Adriana Aguilar-Castillo et al.
SOFT MATTER (2015)
Proinflammatory Cytokines (IL-1α, IL-6) and Hepatocyte Growth Factor in Patients with Alcoholic Liver Cirrhosis
Andrzej Prystupa et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2015)
Effectiveness of Losartan-Loaded Hyaluronic Acid (HA) Micelles for the Reduction of Advanced Hepatic Fibrosis in C3H/HeN Mice Model
Reju George Thomas et al.
PLOS ONE (2015)
Effects of tanshinone IIA on the transforming growth factor β1/Smad signaling pathway in rat cardiac fibroblasts
Cheng-Ye Zhan et al.
INDIAN JOURNAL OF PHARMACOLOGY (2014)
Design of cationic lipid nanoparticles for ocular delivery: Development, characterization and cytotoxicity
Joana F. Fangueiro et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2014)
Inhibitory Effect of Tanshinone IIA on Rat Hepatic Stellate Cells
Ya-Wei Liu et al.
PLOS ONE (2014)
Effect of particle size on the biodistribution of lipid nanocapsules: Comparison between nuclear and fluorescence imaging and counting
Samuli Hirsjaervi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
A new tool to ensure the fluorescent dye labeling stability of nanocarriers: A real challenge for fluorescence imaging
Guillaume Bastiat et al.
JOURNAL OF CONTROLLED RELEASE (2013)
TGF-β in progression of liver disease
Steven Dooley et al.
CELL AND TISSUE RESEARCH (2012)
Explore the Molecular Mechanism of Apoptosis Induced by Tanshinone IIA on Activated Rat Hepatic Stellate Cells
Tai-Long Pan et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2012)
Hepatoprotective effects of baicalein against CCl4-induced acute liver injury in mice
Hai-Li Huang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Fine-tuning of dendritic cell biology by the TNF superfamily
Leslie Summers deLuca et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Development and characterization of a novel lipid nanocapsule formulation of Sn38 for oral administration
Emilie Roger et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2011)
Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting
Marie Morille et al.
BIOMATERIALS (2010)
PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel
Yong Zhang et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2010)
Layer-by-layer surface modification of lipid nanocapsules
Samuli Hirsjaervi et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2010)
Tanshinone IIA protects rat primary hepatocytes against carbon tetrachloride toxicity via inhibiting mitochondria permeability transition
Bin Zhu et al.
PHARMACEUTICAL BIOLOGY (2010)
The anti-inflammatory activities of Tanshinone IIA, an active component of TCM, are mediated by estrogen receptor activation and inhibition of iNOS
Guan-Wei Fan et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2009)
Preclinical factors affecting the pharmacokinetic behaviour of tanshinone IIA, an investigational new drug isolated from Salvia miltiorrhiza for the treatment of ischaemic heart diseases
H. -C. Bi et al.
XENOBIOTICA (2008)
In vivo evaluation of lipid nanocapsules as a promising colloidal carrier for paclitaxel
F. Lacoeuille et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
Grading and staging systems for inflammation and fibrosis in chronic liver diseases
Zachary D. Goodman
JOURNAL OF HEPATOLOGY (2007)
Pharmacokinetics, absorption and tissue distribution of tanshinone IIA solid dispersion
Haiping Hao et al.
PLANTA MEDICA (2006)
Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded lipid nanocapsules
Sandra Peltier et al.
PHARMACEUTICAL RESEARCH (2006)
In vitro investigation on the impact of the surface-active excipients Cremophor EL, Tween 80 and Solutol HS 15 on the metabolism of midazolam
RCB Gonzalez et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2004)
A novel phase inversion-based process for the preparation of lipid nanocarriers
B Heurtault et al.
PHARMACEUTICAL RESEARCH (2002)
Roles of TGF-beta in hepatic fibrosis
AM Gressner et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2002)
Grading and staging the histopathological lesions of chronic hepatitis. The Knodell histology activity index and beyond
EM Brunt
HEPATOLOGY (2000)
Share Paper
